Surgical strategy and optimal timing of tracheostomy in patients with COVID-19: Early experiences in Japan.

Abstract

OBJECTIVE:

Tracheostomy is an important surgical procedure for coronavirus disease-2019 (COVID-19) patients who underwent prolonged tracheal intubation. Surgical indication of tracheostomy is greatly affected by the general condition of the patient, comorbidity, prognosis, hospital resources, and staff experience. Thus, the optimal timing of tracheostomy remains controversial.

METHODS:

We reviewed our early experience with COVID-19 patients who underwent tracheostomy at one tertiary hospital in Japan from February to September 2020 and analyzed the timing of tracheostomy, operative results, and occupational infection in healthcare workers (HCWs).

RESULTS:

Of 16 patients received tracheal intubation with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, five patients (31%) received surgical tracheostomy in our hospital. The average consultation time for surgical tracheostomy was 7.4 days (range, 6 - 9 days) from the COVID-19 team to the otolaryngologist. The duration from tracheal intubation to tracheostomy ranged from 14 to 27 days (average, 20 days). The average time of tracheostomy was 27 min (range, 17 - 39 min), and post-wound bleeding occurred in only one patient. No significant differences in hemoglobin (Hb) levels were found between the pre- and postoperative periods (mean: 10.2 vs. 10.2 g/dl, p = 0.93). Similarly, no difference was found in white blood cell (WBC) count (mean: 12,200 vs. 9,900 cells /µl, p = 0.25). After the tracheostomy, there was no occupational infection among the HCWs who assisted the tracheostomy patients during the perioperative period.

CONCLUSION:

We proposed a modified weaning protocol and surgical indications of tracheostomy for COVID-19 patients and recommend that an optimal timing for tracheostomy in COVID-19 patients of 2 - 3 weeks after tracheal intubation, from our early experiences in Japan. An experienced multi-disciplinary tracheostomy team is essential to perform a safe tracheostomy in patients with COVID-19 and to minimize the risk of occupational infection in HCWs.

• Authors: Naoki Nishio, Mariko Hiramatsu, Yukari Goto, Yuichiro Shindo, Takanori Yamamoto, Naruhiro Jingushi, Keiko Wakahara, Michihiko Sone
• Journal: Auris, nasus, larynx (Auris Nasus Larynx) Vol. 48 Issue 3 Pg. 518-524 (Jun 2021) ISSN: 1879-1476 [Electronic] Netherlands
• PMID: 33272716 (Publication Type: Journal Article)
• Copyright: Copyright © 2020. Published by Elsevier B.V.

Topics

• Aged
• COVID-19 (therapy)
• Female
• Humans
• Japan
• Male
• Middle Aged
• Personal Protective Equipment
• Respiration, Artificial (methods)
• Respiratory Insufficiency (therapy)
• Retrospective Studies
• SARS-CoV-2
• Time Factors
• Tracheostomy (methods)
• Treatment Outcome
• Ventilator Weaning